B-细胞淋巴瘤因子2(Bcl2)重组蛋白

B-细胞淋巴瘤因子2(Bcl2)重组蛋白

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

B-Cell CLL/Lymphoma 2

[ PROPERTIES ]

Source: Prokaryotic expression

Host: E.coli

Residues: Ala2~Asp211

Tags: N-terminal His Tag

Subcellular Location: Exosome

Purity: > 97%

Traits: Freeze-dried powder

Buffer formulation: 20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.

Original Concentration: 200µg/mL

Applications: Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 6.7

Predicted Molecular Mass: 26.7kDa

Accurate Molecular Mass: 26kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do notvortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles. Store at 2-8ºC for one month. Aliquot and store at -80ºC for 12 months.Stability Test: The thermal stability is described by the loss rate. The loss rate was determinedby accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no

obvious degradation and precipitation were observed. The loss rate is less than 5% within theexpiration date under appropriate storage condition.

[ SEQUENCE ]

[ IDENTIFICATION ]

Figure . Gene Sequencing (extract)

[ IMPORTANT NOTE ]

The kit is designed for research use only, we will not be responsible for any issue if the kit wasused in clinical diagnostic or any other procedures.

特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！